PAPER Alberio T, Bondi H, Colombo F, Alloggio I, Pieroni L, Urbani A, Fasano M
SEARCH RESULTS
329960 RESULTS
PAPER Strouwen C, Molenaar EA, Keus SH, Münks L, Munneke M, Vandenberghe W, Bloem BR, Nieuwboer A
Protocol for a randomized comparison of integrated versus consecutive dual task practice in Parkinson's disease: the DUALITY trial.
BMC Neurol. 2014 Mar 27;14:61. PubMed: 24674594PAPER Fieblinger T, Sebastianutto I, Alcacer C, Bimpisidis Z, Maslava N, Sandberg S, Engblom D, Cenci MA
Mechanisms of dopamine D1 receptor-mediated ERK1/2 activation in the parkinsonian striatum and their modulation by metabotropic glutamate receptor type 5.
J Neurosci. 2014 Mar 26;34(13):4728-40. PubMed: 24672017PAPER Birsa N, Norkett R, Wauer T, Mevissen TE, Wu HC, Foltynie T, Bhatia K, Hirst WD, Komander D, Plun-Favreau H, Kittler JT
K27 ubiquitination of the mitochondrial transport protein Miro is dependent on serine 65 of the Parkin ubiquitin ligase.
J Biol Chem. 2014 Mar 26; PubMed: 24671417Joan Irwin
Alana Changoor
New Role for PINK1 Offers Clues about Parkinson's Pathology
RESEARCH NEWS 2014-03-28 Research News Researchers have zeroed in on a mechanism that may promote the earliest stages of mitochondrial decline in Parkinson’s disease (PD). Mutations that hinder the kinase activity of the mitochondria-associated protein PINK1 trigger the derailmen
Researchers Build on GWAS to Parse Genetic Players in AD and PD
CONFERENCE COVERAGE 2014-03-28 Conference Coverage The train of discovery powered by genome-wide association studies (GWAS) is losing steam, so researchers are turning to a different experimental fuel to drive progress on the genetics of Alzheimer's and Parkinson's diseases.
PAPER Keller MF, Saad M, Bras J, Bettella F, Nicolaou N, Simón-Sánchez J, Mittag F, Büchel F, Sharma M, Gibbs JR, Schulte C, Moskvina V, Durr A, Holmans P, Kilarski LL, Guerreiro R, Hernandez DG, Brice A, Ylikotila P, Stefánsson H, Majamaa K, Morris HR, Williams N, Gasser T, Heutink P, Wood NW, Hardy J, Martinez M, Singleton AB, Nalls MA, International Parkinson's Disease Genomics Consortium (IPDGC), Wellcome Trust Case Control Consortium 2 (WTCCC2)
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.
Hum Mol Genet. 2012 Nov 15;21(22):4996-5009. Epub 2012 Aug 13 PubMed: 22892372PAPER Koudinov A, Koudinova NV, Beisiegel U
Cholesterol disbalance at neuromuscular junctions and CNS synapses: a unifying cause of degeneration
BMJ (26 February 2002)PAPER Koudinov AR, Koudinova NV
Beware the simplification in defining neurodegenerative diseases
BMJ (24 June 2002)PAPER Williams A
Defining neurodegenerative diseases.
BMJ. 2002 Jun 22;324(7352):1465-6. PubMed: 12077015Dexter Tagwireyi
University of Zimbabwe
PAPER Leissring MA, Yamasaki TR, Wasco W, Buxbaum JD, Parker I, LaFerla FM
Calsenilin reverses presenilin-mediated enhancement of calcium signaling.
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8590-3. PubMed: 10900016PAPER Duce JA, Hollander W, Jaffe R, Abraham CR
Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain.
Neurobiol Aging. 2006 Apr;27(4):633-44. Epub 2005 Jun 29 PubMed: 15992964Current Filters
No filters selected